Aortic graft infections: Treatment with arterial allograft

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Since its reintroduction by Kieffer in 1991, many authors have used arterial allografts for surgical management of vascular prosthetic graft infection. During a decade, 25 patients with aortic graft infection were treated using in situ revascularization with arterial allograft. There were 23 male and 2 female patients of mean age of 65.7 ± 8.8 years (range, 43-78). Antibiotic therapy was administered for a mean time of 26 ± 5 days (range, 21-45) in the postoperative period. The mean follow-up time was 2.3 ± 3 years (range, 22 days-8.7 years). The mean in-hospital postoperative stay was 29.6 ± 14 days (range, 9-68). An aorto-enteric fistula (AEF) was present in 11 patients (44%), producing gastrointestinal bleeding. The overall mortality rate was 13 of 23 (56.5%) patients. The allograft-related mortality rate was 5 of 23 (22%). The overall allograft-complicated patient rate was 15 of 23 (65%); we observed 18 allograft ruptures in 12 patients and 8 allograft thromboses in 6 patients. The overall amputation rate was 8.7% (2 of 23). Age of the recipient older than 69 years (P = .02), positive preoperative marked-leukocyte scanning (P = .04), and persistent postoperative leukocytosis (P = .03) were significant variables associated with an increased risk of allograft-related complications. The use of arterial allografts for aortic graft infections represents an interesting alternative for the treatment of graft infection. Nevertheless, there are some problems related to the durability of this type of graft, which can still be considered as a "bridge transplant."

Original languageEnglish
Pages (from-to)2694-2696
Number of pages3
JournalTransplantation Proceedings
Volume37
Issue number6
DOIs
Publication statusPublished - 2005

Fingerprint

Allografts
Transplants
Infection
Therapeutics
Mortality
Leukocytosis
Amputation
Postoperative Period
Fistula
Blood Vessels
Rupture
Length of Stay
Thrombosis
Leukocytes
Hemorrhage
Anti-Bacterial Agents

ASJC Scopus subject areas

  • Surgery
  • Transplantation

Cite this

Aortic graft infections : Treatment with arterial allograft. / Pirrelli, S.; Arici, V.; Bozzani, A.; Odero, A.

In: Transplantation Proceedings, Vol. 37, No. 6, 2005, p. 2694-2696.

Research output: Contribution to journalArticle

@article{4b8ce40525db40d6b3d3714ea048498d,
title = "Aortic graft infections: Treatment with arterial allograft",
abstract = "Since its reintroduction by Kieffer in 1991, many authors have used arterial allografts for surgical management of vascular prosthetic graft infection. During a decade, 25 patients with aortic graft infection were treated using in situ revascularization with arterial allograft. There were 23 male and 2 female patients of mean age of 65.7 ± 8.8 years (range, 43-78). Antibiotic therapy was administered for a mean time of 26 ± 5 days (range, 21-45) in the postoperative period. The mean follow-up time was 2.3 ± 3 years (range, 22 days-8.7 years). The mean in-hospital postoperative stay was 29.6 ± 14 days (range, 9-68). An aorto-enteric fistula (AEF) was present in 11 patients (44{\%}), producing gastrointestinal bleeding. The overall mortality rate was 13 of 23 (56.5{\%}) patients. The allograft-related mortality rate was 5 of 23 (22{\%}). The overall allograft-complicated patient rate was 15 of 23 (65{\%}); we observed 18 allograft ruptures in 12 patients and 8 allograft thromboses in 6 patients. The overall amputation rate was 8.7{\%} (2 of 23). Age of the recipient older than 69 years (P = .02), positive preoperative marked-leukocyte scanning (P = .04), and persistent postoperative leukocytosis (P = .03) were significant variables associated with an increased risk of allograft-related complications. The use of arterial allografts for aortic graft infections represents an interesting alternative for the treatment of graft infection. Nevertheless, there are some problems related to the durability of this type of graft, which can still be considered as a {"}bridge transplant.{"}",
author = "S. Pirrelli and V. Arici and A. Bozzani and A. Odero",
year = "2005",
doi = "10.1016/j.transproceed.2005.06.098",
language = "English",
volume = "37",
pages = "2694--2696",
journal = "Transplantation Proceedings",
issn = "0041-1345",
publisher = "Elsevier USA",
number = "6",

}

TY - JOUR

T1 - Aortic graft infections

T2 - Treatment with arterial allograft

AU - Pirrelli, S.

AU - Arici, V.

AU - Bozzani, A.

AU - Odero, A.

PY - 2005

Y1 - 2005

N2 - Since its reintroduction by Kieffer in 1991, many authors have used arterial allografts for surgical management of vascular prosthetic graft infection. During a decade, 25 patients with aortic graft infection were treated using in situ revascularization with arterial allograft. There were 23 male and 2 female patients of mean age of 65.7 ± 8.8 years (range, 43-78). Antibiotic therapy was administered for a mean time of 26 ± 5 days (range, 21-45) in the postoperative period. The mean follow-up time was 2.3 ± 3 years (range, 22 days-8.7 years). The mean in-hospital postoperative stay was 29.6 ± 14 days (range, 9-68). An aorto-enteric fistula (AEF) was present in 11 patients (44%), producing gastrointestinal bleeding. The overall mortality rate was 13 of 23 (56.5%) patients. The allograft-related mortality rate was 5 of 23 (22%). The overall allograft-complicated patient rate was 15 of 23 (65%); we observed 18 allograft ruptures in 12 patients and 8 allograft thromboses in 6 patients. The overall amputation rate was 8.7% (2 of 23). Age of the recipient older than 69 years (P = .02), positive preoperative marked-leukocyte scanning (P = .04), and persistent postoperative leukocytosis (P = .03) were significant variables associated with an increased risk of allograft-related complications. The use of arterial allografts for aortic graft infections represents an interesting alternative for the treatment of graft infection. Nevertheless, there are some problems related to the durability of this type of graft, which can still be considered as a "bridge transplant."

AB - Since its reintroduction by Kieffer in 1991, many authors have used arterial allografts for surgical management of vascular prosthetic graft infection. During a decade, 25 patients with aortic graft infection were treated using in situ revascularization with arterial allograft. There were 23 male and 2 female patients of mean age of 65.7 ± 8.8 years (range, 43-78). Antibiotic therapy was administered for a mean time of 26 ± 5 days (range, 21-45) in the postoperative period. The mean follow-up time was 2.3 ± 3 years (range, 22 days-8.7 years). The mean in-hospital postoperative stay was 29.6 ± 14 days (range, 9-68). An aorto-enteric fistula (AEF) was present in 11 patients (44%), producing gastrointestinal bleeding. The overall mortality rate was 13 of 23 (56.5%) patients. The allograft-related mortality rate was 5 of 23 (22%). The overall allograft-complicated patient rate was 15 of 23 (65%); we observed 18 allograft ruptures in 12 patients and 8 allograft thromboses in 6 patients. The overall amputation rate was 8.7% (2 of 23). Age of the recipient older than 69 years (P = .02), positive preoperative marked-leukocyte scanning (P = .04), and persistent postoperative leukocytosis (P = .03) were significant variables associated with an increased risk of allograft-related complications. The use of arterial allografts for aortic graft infections represents an interesting alternative for the treatment of graft infection. Nevertheless, there are some problems related to the durability of this type of graft, which can still be considered as a "bridge transplant."

UR - http://www.scopus.com/inward/record.url?scp=25144507220&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=25144507220&partnerID=8YFLogxK

U2 - 10.1016/j.transproceed.2005.06.098

DO - 10.1016/j.transproceed.2005.06.098

M3 - Article

C2 - 16182787

AN - SCOPUS:25144507220

VL - 37

SP - 2694

EP - 2696

JO - Transplantation Proceedings

JF - Transplantation Proceedings

SN - 0041-1345

IS - 6

ER -